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Key questions
What is already known about this subject?
 ► Cardiac rehabilitation (CR) is effective in improving 
patient outcomes and reducing the risk of future 
cardiac events.
 ► Despite being recommended in national guidelines, 
approximately 50% of eligible patients do not take 
part or do not complete a programme.
What does this study add?
 ► The web-based programme offers an alternative 
way to complete CR in those who decline or drop 
out of a conventional hospital programme.
 ► The wed-based alternative was feasible to deliv-
er and promising signals were noted in secondary 
outcomes.
How might this impact on clinical practice?
 ► We believe that this web-based approach could pro-
vide an acceptable way to increase the provision of 
CR for those unable (or unwilling) to attend conven-
tional programmes; or to be an alternative mode of 
CR delivery in a full, choice-based CR menu.
 ► In turn, this could reduce the risk of future cardiac 
events in those able to attend a programme.
AbstrAct
Introduction Cardiac rehabilitation (CR) is typically 
delivered in hospital-based classes and is recommended 
to help people reduce their risk of further cardiac events. 
However, many eligible people are not completing the 
programme. This study aimed to assess the feasibility 
of delivering a web-based CR intervention for those who 
decline/drop out from usual CR.
Intervention A web-based CR programme for 6 months, 
facilitated with remote support.
Methods Two-centre, randomised controlled feasibility 
trial. Patients were randomly allocated to web-based CR/
usual care for 6 months. Data were collected to inform 
the design of a larger study: recruitment rates, quality of 
life (MacNew), exercise capacity (incremental shuttle walk 
test) and mood (Hospital Anxiety and Depression Scale). 
Feasibility of health utility collection was also evaluated.
Results 60 patients were randomised (90% male, mean 
age 62±9 years, 26% of those eligible). 82% completed all 
three assessment visits. 78% of the web group completed 
the programme. Quality of life improved in the web group 
by a clinically meaningful amount (0.5±1.1 units vs 
0.2±0.7 units: control). Exercise capacity improved in both 
groups but mood did not change in either group. It was 
feasible to collect health utility data.
Conclusions It was feasible to recruit and retention to 
the end of the study was good. The web group reported 
important improvements in quality of life. This intervention 
has the opportunity to increase access to CR for patients 
who would otherwise not attend. Promising outcomes and 
recruitment suggest feasibility for a full-scale trial.
Trial registration number 10726798.
InTRoduCTIon
Coronary heart disease (CHD) affects over 
2.3 million people in the UK.1 There is a very 
large cost to both the individual, in terms of 
loss of quality of life, and to society, in terms 
of healthcare costs and loss of productivity. It 
has been estimated that the cumulative cost 
of cardiovascular disease (CVD) to the UK 
economy is in the region of £30 billion annu-
ally,2 through direct service provision, lost 
productivity and informal care.3 The acute 
and ongoing management of individuals with 
CHD has been outlined in many national and 
international guidelines,4 and acknowledges 
the importance of cardiac rehabilitation 
(CR) in the care pathway of these individuals. 
CR is commonly a structured and supervised 
package of care that supports individuals with 
CHD to achieve their best possible levels of 
physical, psychological and social function.5–7
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Many national and international guidelines on 
management of CHD acknowledge the importance of 
CR in the care pathway, including the National Institute 
for Health and Care Excellence (NICE) clinical guide-
line 172 on myocardial infarction (MI),8 94 on unstable 
angina and non-ST segment elevation MI9 and guide-
line 108 on chronic heart failure.10 The CVD outcomes 
strategy (2013) set an ambitious target for 65% of people 
discharged from hospital with a primary diagnosis of 
acute MI or a surgical revascularisation to be offered 
CR.11
Despite national guidance, the most recent National 
Audit of Cardiac Rehabilitation indicates that only 51% of 
eligible patients actually receive CR.12 There also appears 
to be unacceptable variation in uptake (30%–90%) across 
the UK, underpinned by complex reasons; some related 
to the organisation and system of delivery13 and others to 
patients’ individual choice. Factors related to rehabilita-
tion non-attendance that have been identified comprised 
employment commitments, difficulties with transport, 
lack of time, distance to travel to rehabilitation and embar-
rassment related to attending rehabilitation.14–16 There 
appears to be some consensus around barriers that argue 
for the development of alternative formats and modes 
of rehabilitation delivery, so that access is broadened.17 
Currently within practice, the ‘Heart Manual’18 and the 
‘Angina Plan’19 are alternative paper-based home reha-
bilitation options, but are not widely delivered. Studies 
have shown that most patients with CHD who are still 
working would prefer a home-based CR programme.20 
Interestingly, CR delivered either as a supervised or facil-
itated self-delivered programme has equivalent positive 
outcomes.21 The audit also identified that 33% of patients 
do not complete a CR programme and the most cited 
reason for attrition or failure to complete group-based 
CR is the need to have ‘return to work’.12
There is considerable interest in digital health as 
a means of delivering healthcare for individuals with 
long-term conditions, where a standard intervention 
is delivered in a way that is not geographically or time 
constrained. An increasing proportion of retired people 
are using the internet, reflecting the typical rehabilita-
tion population. In the UK, 79% and 76% of men and 
women aged between 65 and 74 years respectively had 
used the internet within the previous 3 months.22 Among 
adults aged 75+ years, internet use increased from 19.9% 
to 40.5% from 2011 to 2017 (ie, 3% a year).22
Studies carried out across Europe and North America 
have investigated the efficacy of web-based interventions 
for those with heart disease.23–26 The largest was reported 
in 201226; however, it was not a comprehensive rehabil-
itation programme (as defined by the Department of 
Health’s commissioning pack27 and recruited participants 
with a broad range of CVDs). Reid et al24 reported on a 
Canadian study which recruited exclusively people post-
primary percutaneous coronary revascularisation (percu-
taneous coronary intervention (PCI) or angioplasty) who 
were offered a physical activity intervention that was web 
based. The paper reported a benefit in the intervention 
arm not observed in the control arm, suggesting the 
potential value of web-based interventions in this popu-
lation. The Cochrane review of internet-based interven-
tions for the secondary prevention of CHD, published in 
2015, suggested that there was some evidence to support 
improvements in health-related quality of life and 
behaviour change, but there was insufficient evidence to 
draw firm conclusions.28
The University Hospitals of Leicester (UHL) NHS 
Trust has developed a web-based CR programme (‘ACTI-
VATE YOUR HEART’, www. activateyourheart. org. uk). 
This online programme was developed over a number of 
years, and has been tested in two small studies. The first 
was a pilot randomised controlled trial (RCT) in patients 
with angina managed exclusively in primary care.29 
Encouragingly, the data demonstrated improvements in 
angina symptoms, objectively measured physical activity 
and levels of anxiety and depression, compared with the 
control group. A second single cohort observational study 
collected pilot data from patients attending CR at UHL, 
which identified significant improvements (p<0.05) in 
depression, exercise capacity and quality of life (n=106). 
Interestingly 65% of patients reported that they would 
not otherwise have attended CR.30 This has formed the 
basis of a case study on the NICE website (http://www. 
nice. org. uk/ usingguidance/ shar edle arni ngim plem enti 
ngni cegu idance/ exam ples ofim plem entation/ eximpre-
sults. jsp? o= 718), encouraging the use and exploration of 
alternative forms of delivery.
The use of the internet permits greater flexibility of CR 
delivery, as patients are able to complete their programme 
at a place and time that suit them. It is also capable of 
reaching a wider population, especially those patients 
who live in rural areas.31 Studies have highlighted how 
web-based interventions can also help improve knowl-
edge for patients with chronic health conditions.32 There 
may also be benefits to the service, releasing capacity 
for CR specialists to manage more complex patients in 
conventional hospital classes, as well as providing addi-
tional choice for those unwilling to do standard CR.33
objeCTIves
The study aimed to assess the feasibility of delivering a 
trial offering an alternative web-based CR intervention 
for those who decline or drop out from conventional 
supervised CR. The study was a two-centre feasibility 
study, collecting quantitative data to inform the design of 
a definitive clinical trial. The specific objectives were to:
1. Derive an estimate of the number of eligible patients 
at participating centres.
2. Assess the willingness of patients to be randomised to 
this study and a future trial.
3. Determine opportunities and methods to recruit pa-
tients to a future trial.
4. Determine participant adherence to the web-based re-
habilitation programme.
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5. Test methods for the collection of baseline and fol-
low-up clinical data as well as data completeness and 
accuracy.
6. Assess the willingness of participants to allow research-
ers to follow their hospital records/health service data.
7. Identify methods to measure economic costs (health 
and social care resource use and patientborne costs) 
and outcomes (including health utility and return to 
normal work or other activity).
We also collected qualitative data in the form of staff 
and patient interviews (this will be reported in a separate 
paper).
MeTHods
design
A feasibility study to inform the design of a definitive 
RCT. Patients were randomised to either best usual 
care or the web-based programme (‘ACTIVATE YOUR 
HEART’) from two CR centres in the UK (UHL NHS 
Trust (acute) and Lincolnshire Community Health 
Services NHS Trust (community)). The trial is registered 
on the ISRCTN website (ref: 10726798). We aimed to 
recruit people who declined, or were unable to take up or 
dropped out of conventional rehabilitation. These partic-
ipants were recruited from different stages of the rehabil-
itation pathway, including those identified from the CR 
database, or those declining the offer of rehabilitation at 
the time of the initial assessment prior to enrolment onto 
a conventional programme. Outcome measures were 
collected at baseline, 8 weeks and 6 months.
Participants
Inclusion criteria
 ► Confirmed primary diagnosis of CHD (including 
angina, post-MI, post-PCI).
 ► Eligible for conventional CR (eligibility as described 
in guidance from the British Association for Cardi-
ovascular Prevention and Rehabilitation—updated 
2017).34
 ► Access to, familiarity with and ability to use the 
internet. Questions were asked to establish familiarity 
with the internet, for example, use of either online 
shopping/online banking.
 ► People who have recently (<12 months) declined, 
or were unable to take up the invitation of rehabili-
tation. These people are defined as those expressing 
an unwillingness to attend any further stages of the 
programme either at patient assessment or when the 
patient care plan was developed.
 ► People who have recently (<12 months) ‘dropped 
out’ of rehabilitation. These people are defined as 
those not attending two consecutive sessions of the 
comprehensive rehabilitation programme.
Exclusion criteria
 ► No access to the internet, unfamiliar with or unable 
to use the internet.
 ► Individuals who have completed rehabilitation for a 
previous admission in the last 12 months.
 ► Those demonstrating high levels of depression 
(defined by baseline Hospital Anxiety and Depres-
sion Scale (HADS) score35 >11 (moderate depres-
sion)) and poor exercise capacity (defined by poor 
performance on the incremental shuttle walking test 
(ISWT),36 level achieved <3—equivalent to walking 
120 m).
 ► Unable to read English (as the intervention is 
currently only available in English).
Randomisation
Participants were randomised into one of two groups: the 
intervention group (web-based CR programme) and the 
control group (usual care) using a web-based randomisa-
tion system (www. sealedenvelope. com). Randomisation 
was stratified by centre, 30 patients by site, 60 in total. 
Randomisation was performed using permuted blocks, 
with 60% to the intervention and 40% to the control 
group. Unequal randomisation was performed to allow 
for more experience with the intervention group and 
more data (power) in this group to detect adverse events.
Trial interventions
Intervention group: web-based CR programme
‘ACTIVATE YOUR HEART’ (www. activateyourheart. org. 
uk) is an online intervention designed for participants to 
use self-directed at home, facilitated with remote support 
from the CR team. The broad aim of the programme is to 
improve the overall cardiac risk factor profile of patients. 
The intervention is an interactive, password-protected, 
tailored CR programme, contained in a website. The 
programme was developed at the UHL NHS Trust and 
coproduced with healthcare professionals, a software 
development team (HARK2) and a group of patients/
members of the public.
The programme contains four stages and can be 
completed in 8 weeks but access to the site and its 
features continues for 12 months. Before beginning the 
programme each patient receives face-to-face training 
on the website and a written user manual. They then 
complete an online registration form, providing infor-
mation about their current and previous medical history 
and their cardiac risk factors. The website uses this 
information as baseline measurement, and to create an 
individually tailored plan for the patient. Throughout 
the programme, patients have access to a discussion 
forum and an ‘ask the expert’ email facility. CR staff at 
both centres had access to the administration side of the 
website; here they are able to monitor each participant’s 
progress. Participants and the CR team were alerted 
whenever the programme was not being used regularly. 
More details about the programme are reported in a 
previous paper.30
Control group
Participants in this group received best usual care for 
their region. Usual care in the absence of CR would 
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Figure 1 Consolidated Standards of Reporting Trials 
(CONSORT) diagram by treatment group.
comprise a referral back to general practice and general 
advice in the form of standard verbal advice and guidance 
booklets. All participants in the control group were given 
the opportunity to participate in the ‘ACTIVATE YOUR 
HEART’ programme following their 6-month follow-up 
appointment.
Outcome measures
The primary outcome measure in this study was to assess 
the feasibility of recruiting/retaining people who met the 
inclusion criteria; those who have declined/dropped out 
of traditional CR.
We also examined the:
 ► Safety of the trial (adverse event reporting and angina 
symptom diary).
 ► Feasibility of our randomisation process and willing-
ness to be randomised.
 ► Retention rate of participants to the study at 8 weeks 
and 6 months of follow-up.
 ► Feasibility of conducting the outcome measures 
which are proposed for a definitive trial, collected at 
blinded 8-week and 6-month assessments including:
 – Health-related quality of life: the MacNew Heart 
Disease Questionnaire,37measuring physical, emo-
tional and social aspects of quality of life.
 – Exercise capacity: measured using the ISWT,36 
which is a test used to assess cardiorespiratory fit-
ness. An initial practice test was conducted at base-
line to minimise any possible learning effect.
 – Anxiety and depression: measured using the 
HADS.35
 – Self-efficacy: measured using ‘the general self-effi-
cacy scale.38
 – Resource use (health/social care and person-
al costs) questionnaire for healthcare and other 
services received: to identify methods to measure 
costs (health and social care resource use and pa-
tient borne costs) and outcomes (including health 
utility and return to normal work or other activity). 
The questionnaire was devised for the purposes of 
this study by one of the authors (AS) and can be 
found here: http://www. dirum. org/ instruments/ 
details/ 104.
non-clinical study outcomes/process measures
 ► Web usage: total web usage statistics for patients 
assigned to the web-based programme were moni-
tored, along with emails sent to the expert CR team.
 ► Intervention completion rates among intervention 
group participants.
Sample size estimation and recruitment target
As this was a feasibility study, a formal sample size calcula-
tion was not required to detect between-group changes. 
We therefore aimed to recruit 30 individuals at each site 
within the recruitment phase of the study, 60 individuals 
in total. This was a conservative number, anticipating that 
each site will recruit approximately three participants per 
month. Data from 60 participants were deemed reason-
able to assess the recruitment/retention rate and allow 
for planning the subsequent final trial by obtaining esti-
mates of potential outcomes (ie, health-related quality of 
life) with sufficient precision (ie, with an SE of less than 
8% for estimated proportions). This is in keeping with 
recommendations of 30 participants required in feasi-
bility/pilot studies to estimate a parameter.39 Further-
more, a recent audit of UK feasibility studies found that 
the median sample size for a two-arm trial was 36 and 30 
per arm, respectively, for dichotomous and continuous 
endpoints.40
Quantitative data analysis
Data were entered and stored on a secure web-based 
system (REDCAP) which has discrepancy management 
features. Data were then transferred from REDCAP to 
the Statistical Package for the Social Sciences (SPSS) V.18 
(SPSS). Analysis was primarily descriptive, that is, estima-
tion of means and SDs, proportion of patients eligible/
willing to participate in the study, dropouts and comple-
tion rates. In line with the accepted practice for feasibility 
studies, no p (significance) values/inferential statistics 
are presented.
ResulTs
Sixty patients were recruited and randomised to the study 
between December 2015 and April 2017: 37 to the web 
group and 23 to the control group. Figure 1 shows the 
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Table 1 Baseline characteristics of the two groups
Web group 
(n=37)
Control group 
(n=23)
Gender
  Male, n (%) 33 (89)
21 (9) 
Age
  Mean (SD) 62 (10) 61 (8)
Ethnicity 
  White, n (%) 37 (100) 21 (91)
Marital status 
  Married, n (%) 27 (75) 17 (74)
BMI
  Mean (SD) 28 (11) 29 (12)
Family history
  Yes, n (%) 20 (54) 6 (26)
Employment status, n (%) 
  Employed 14 (38) 9 (39)
  Self-employed 1 (3) 1 (4)
  Retired 21 (57) 12 (52)
  Part-time and retired 1 (3) 0 (0)
  Unpaid work and retired 0 (0) 1 (4)
Previous cardiac event, n (%)
  IHD (Ischaemic Heart Disease) 7 (19) 1 (4)
  Angina 9 (24) 6 (26)
  PCI 6 (16) 4 (17)
  Cardiac arrest 5 (14) 2 (9)
  Other 10 (27) 10 (44)
Medication, n (%) 
  Beta blockers 33 (89) 18 (78)
  ACE (Angiotensin Converting 
Enzyme) inhibitors 32 (87) 19 (83)
  GTN (Glyceryl Trinitrate) spray 29 (78) 20 (87)
  Anticoagulants 19 (51) 11 (48)
  Aspirin 35 (95) 21 (91)
  Statins 35 (95) 21 (91)
  Diuretics 9 (24) 2 (9)
  Calcium channel blocker 4 (11) 5 (22)
  Antiarrhythmic 6 (16) 16 (70)
BMI, body mass index;GTN, Glyceryl trinitrate; IHD, Ischeamic 
heart disease; PCI, percutaneous coronary intervention.
Table 2 Clinical outcome measures at baseline, 8-weeks and 6-months in both groups. Results are presented as mean (SD)
Baseline 8 weeks 6 months
Web Con Web Con Web Con
MacNew overall score 5.9 (1.0) 6.0 (0.8) 6.2 (0.7) 6.2 (0.6) 6.5 (0.5) 6.2 (0.6)
ISWT (m) 437.6 (153.6) 458.0 (153.6) 479.0 (180.1) 492.0 (167.9) 491.3 (192) 564.7 (152.9)
HADS Anxiety Score 3.9 (3.2) 4.0 (2.7) 3.4 (3.6) 4.8 (3.6) 3.0 (3.3) 3.8 (3.0)
HADS Depression Score 2.7 (2.7) 2.5 (2.6) 1.7 (2.1) 2.4(2.2) 1.5 (1.4) 2.4 (2.5)
General Self-Efficacy Scale score 33.6 (4.3) 35.4 (4.0) 35.2 (3.5) 35.3 (4.8) 35.8 (3.6) 35.7 (4.2)
Results are presented as mean (SD).
HADS, Hospital Anxiety and Depression Scale;ISWT, incremental shuttle walking test.
flow of eligibility, screening, randomisation and follow-up 
in the study. The main reason for exclusion to the study 
was that patients did not meet the inclusion criteria, 
n=442 (ie, no confirmed diagnosis of CHD, completed 
CR in the last 12 months, comorbidities/contraindica-
tions to exercise or not web literate). Of those eligible 
to be randomised, n=60 or 26% were willing to take part 
in the trial. Tables 1 and 2 show the baseline characteris-
tics and clinical outcomes of the two groups. The groups 
appear well matched at baseline though no statistical tests 
were performed to confirm this.
More patients dropped out/were lost to follow-up from 
the web intervention group (n=7) compared with four in 
the control group by 6 months.
Retention rates in the trial were excellent: overall 54 
patients attended the 8-week assessment (90%; 95% 
CI 79% to 96%) and 49 patients attended the 6-month 
assessment (82%; 95% CI 70% to 90%).
There were two adverse events in the web group and 
four in the control group—but all were deemed unre-
lated to the study procedures and interventions. At 8 
weeks, four patients in the web group and one control 
patient reported at least one episode of angina in their 
symptom diaries. These episodes were relieved with glyc-
eryl trinitrate spray and/or rest.
The most fruitful method of recruitment was to 
capture patients at the point of declining rehabilitation 
in a one-to-one assessment (>80% of those recruited) 
compared with retrospectively contacting those who had 
declined or dropped out of a programme previously.
 table 3shows the change within groups for the clin-
ical outcomes at 8 weeks and 6 months. The change in 
the MacNew total score at 6 months met suggested the 
minimum clinical important difference of 0.541 for this 
outcome in the web group.
It was feasible to measure costs (health and social care 
resource use and patientborne costs) and outcomes 
(including health utility and return to normal work or 
other activity) using the Resource Use Questionnaire 
designed for this study—see here: http://www. dirum. 
org/ instruments/ details/ 104. The overall completion 
of this questionnaire was 90% across both groups at 6 
months. In future work, both costs and outcomes will be 
analysed and reported using standard national Health 
Technology Assessment Framework standards.42
Web usage statistics are shown in figure 2A–C. Patients 
were able to double their exercise time (in minutes) 
from baseline to 8 weeks and this was maintained at the 
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Table 3 Changes in clinical outcome measures at 8 weeks 
and 6 months in both groups
8 weeks 6 months
Web Control Web Control
MacNew overall 
score 0.3 (1.0) 0.2 (0.8) 0.5 (1.1) 0.2 (0.7)
ISWT (m) 45.5 (57.0) 50.0 (76.9) 52.9 (76.8) 85.9 (115.2)
HADS Anxiety 
Score −0.3 (3.0) 0.7 (3.1) −0.4 (3.3) −0.2 (2.8)
HADS 
Depression 
Score −0.3 (3.0) 0.7 (3.1) −0.8 (2.6) 0.1 (1.6)
General Self-
Efficacy Scale 
score 1.5 (4.1) −0.1 (2.9) 2.1 (5.1) −0.3 (1.6)
Results are presented as mean (SD).
HADS, Hospital Anxiety and Depression Scale;ISWT, incremental 
shuttle walking test.
Figure 2 Web usage statistics. (A) Average minutes of 
exercise logged per week. (B) Average number of log-ins, 
phone calls and emails. (C) Completion of web stages.
6-month assessment. The average number of log-ins was 
three times per week at the 8-week mark and twice a week 
at 6 months. Phone calls and emails from patients to 
staff were low and patients did not use the group forum. 
Twenty-nine (of the 37 participants) had completed the 
web programme at 6 months (78%) and some were still 
working their way through the programme.
dIsCussIon
CR is a highly effective intervention in the management 
of patients with CHD.5 Despite its numerous benefits, it is 
an underused treatment, with around only half of eligible 
patients in the UK and around 30% in Europe accessing 
a programme.12 43 Alternative or more flexible ways of 
delivering CR therefore ought to be considered.
The data from this study show that a web-based CR 
programme (‘ACTIVATE YOUR HEART’) has the poten-
tial to be an acceptable way to increase the provision of 
CR for those unable (or unwilling) to attend a conven-
tional programme. If alternative forms of CR allow more 
patients to access a service, this in turn could reduce the 
risk of future cardiac events for those able to attend a 
programme.
Of those who were eligible, a quarter agreed to partici-
pate. For future studies, we may need to review the inclu-
sion criteria to allow those with more complex needs to 
access the web programme (including those with low 
shuttle walk test performance or high levels of anxiety or 
depression). Also, we expect that over time, the numbers 
of patients who are web literate will increase. This would 
be in line with the recent internet use statistics revealing 
that internet use in those aged 65 years and over is 
catching up with the younger age groups.22 Furthermore, 
we are aware that the NHS priorities around the use of 
technology in healthcare are changing and we would 
expect the capacity for digital health interventions to 
continue to grow. The NHS has pledged in its 5-year plan 
to ‘train our staff so that they are able to support those 
who are unable or unwilling to use new technologies.’44
We were encouraged by the high levels of engage-
ment with the web programme, as measured by numbers 
of log-ins, exercise sessions logged and that 78% had 
completed the programme at 6 months (with others 
still working their way through the programme). It was 
perhaps surprising that patients took longer than the 
anticipated 8 weeks to complete the online programme. 
However, patients had access to the ‘ACTIVATE YOUR 
HEART’ programme for 1 year, therefore the programme 
can be completed at the patients’ own pace. Furthermore, 
access to the programme for this protracted period has 
the potential to improve maintenance, though we did not 
measure long-term follow-up of outcomes as part of this 
study. Interestingly, patients required minimal support 
from healthcare staff in terms of phone calls and emails. 
As this is the only part of web-based CR programme 
where costs increase with increasing numbers of partic-
ipants (increased staff time); this suggests that the costs 
with increasing numbers will remain low. We were able 
to identify the best method of recruitment in this feasi-
bility study. This was to approach patients prospectively 
at the point of declining rehabilitation in a one-to-one 
assessment (>80% of those recruited) as opposed to 
retrospectively contacting those who had declined or 
dropped out of a programme previously. It may be that 
uptake at this stage was also influenced by the healthcare 
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professional introducing the research study (ie, the clin-
ical rehabilitation team and not the research team). 
We would use this recruitment strategy going forward 
to a full trial. However, we should not limit the offer of 
web-based rehabilitation to only those who decline a 
conventional, class-based programme. Last year, 65 344 
eligible patients missed out on a life-saving intervention 
that also improves quality of life.12 CR ought to be a full 
menu with genuine choice and resources that support 
patient preference. Web-based rehabilitation is one of 
the innovations required to future proof CR.
Furthermore, it was feasible to collect all clinical, 
non-clinical and health utility outcomes in this trial. 
Finally, there was excellent completion of all study 
outcomes and procedures, with 82% of individuals 
attending all three assessment visits.
While this feasibility study was not powered to test 
clinical effectiveness of the web programme, we are 
encouraged by the clinically worthwhile gains shown 
in the MacNew Quality of Life Questionnaire in the 
web group and some small positive signals in the other 
outcome measures. Overall, we were able to show that the 
web-based CR programme was safe (low adverse events 
and attrition unrelated to the study intervention) and 
could secure improvements associated with conventional 
CR. Mood (anxiety and depression) and self-efficacy did 
not really improve in either group, though it is important 
to note a potential floor effect since the groups both had 
low levels of anxiety and depression and high self-effi-
cacy scores at the programme’s start, reducing scope for 
change. We did not anticipate the large change in the 
ISWT of the control group at 6 months (86 m vs 53 m in 
the web group), and are unsure of the reasons for this 
change. It may be argued that the mere act of performing 
an outcome measure may influence the subsequent 
outcome. In other words, the performance of an ISWT 
in itself could be considered an intervention and have 
an effect on the patients’ confidence to complete that 
test.45 46 However, as stated previously, the self-efficacy 
scores (an indicator of confidence) did not improve in 
either group. In a full-scale trial, it may be appropriate 
to perform a sensitivity analysis to examine the extent to 
which results are ‘affected by changes in methods, models, 
values of unmeasured variables, or assumptions.’47
ConClusIon
This feasibility study of web-based CR versus usual care has 
provided us early signs of patient benefit and produced 
useful information about how best to recruit to a defin-
itive trial. We have been encouraged by some promising 
outcomes and the data suggest feasibility for a full-scale 
trial. There is the potential for a trial looking at the effec-
tiveness of the web-based programme in decliners. There 
is also the scope to evaluate web-based CR as part of a full 
menu of options.
This intervention has the opportunity to increase access 
to CR for patients who would otherwise not attend. Or to 
be an alternative mode of CR delivery in a full, choice-
based CR menu. In turn, this could reduce the risk of 
future cardiac events and therefore be cost saving .
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